Access to anti-retroviral drugs, female in IDA total
IDA total: Access to anti-retroviral drugs, female was 87.1% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in IDA total, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
IDA total recorded 87.1% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
The figure is up 3.6% on the previous year and up 83.8% over ten years.
Over the whole period, access to anti-retroviral drugs, female in IDA total peaked at 87.1% in 2024 and was at its lowest, 0.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in IDA total, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.2% | +2577.8% |
| 2003 | 0.4% | +120.6% |
| 2004 | 1.7% | +285.8% |
| 2005 | 3.4% | +102.3% |
| 2006 | 6.2% | +82.6% |
| 2007 | 10.0% | +60.5% |
| 2008 | 14.3% | +43.2% |
| 2009 | 18.5% | +29.6% |
| 2010 | 23.8% | +28.2% |
| 2011 | 28.9% | +21.7% |
| 2012 | 34.8% | +20.4% |
| 2013 | 40.2% | +15.4% |
| 2014 | 47.4% | +17.8% |
| 2015 | 52.6% | +11.0% |
| 2016 | 58.8% | +11.6% |
| 2017 | 64.8% | +10.4% |
| 2018 | 67.0% | +3.4% |
| 2019 | 70.6% | +5.4% |
| 2020 | 74.4% | +5.3% |
| 2021 | 77.5% | +4.2% |
| 2022 | 81.1% | +4.7% |
| 2023 | 84.1% | +3.7% |
| 2024 | 87.1% | +3.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.5% | 0.0% | 18.5% | 10 |
| 2010s | 48.9% | 23.8% | 70.6% | 10 |
| 2020s | 80.9% | 74.4% | 87.1% | 5 |
Countries ranked near IDA total
More gender data for IDA total
- Labor force, female 308.79 million (2025)
- Labor force, female, per capita 0.1554 units per person (2025)
- Labor force, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Labor force, female, annual growth rate 2.69 % change on previous year (2025)
- Labor force, female, per square kilometre 11.72 units per square kilometre (2023)
- Incidence of HIV, ages 15-49, female 0.5731 per 1,000 uninfected female population ages 15-49 (2024)
- Incidence of HIV, ages 15-49, male 0.3525 per 1,000 uninfected male population ages 15-49 (2024)
- Incidence of HIV, ages 15-24, female 0.7217 per 1,000 uninfected female population ages 15-24 (2024)
- Incidence of HIV, ages 15-24, male 0.2779 per 1,000 uninfected male population ages 15-24 (2024)
- Ratio of female to male youth unemployment rate (% ages 15-24) 120.1% (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in IDA total?
- Access to anti-retroviral drugs, female in IDA total was 87.1% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in IDA total?
- The highest recorded value was 87.1% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in IDA total?
- The lowest recorded value was 0.0% in 2000.
- How does IDA total rank for access to anti-retroviral drugs, female?
- IDA total ranks 4th out of 19 groups with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in IDA total?
- Over the last ten years it is up 83.8%. The long-run trend across the full record is volatile.
- Where does this IDA total data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.